PasTel
Post-Authorisation Safety Study (PASS) TachoSil Evaluation (PasTel):
Short- and longterm safety evaluation of TachoSil in paediatric population.
Short- and longterm safety evaluation of TachoSil in paediatric population.
Dear Sir or Madam,
We would like to invite you to participate in a multicentre, observational, post-authorisation safety study evaluating the short- and long-term safety of TachoSil in the paediatric population.
In order to start the study please log in with the details obtained in the account creation process.
We would like to invite you to participate in a multicentre, observational, post-authorisation safety study evaluating the short- and long-term safety of TachoSil in the paediatric population.
In order to start the study please log in with the details obtained in the account creation process.
CRO
Biostat Sp. z o.o.
ul. Kowalczyka 17, 44-206 Rybnik
phone: +48 530 714 118
e-mail: [email protected]
ul. Kowalczyka 17, 44-206 Rybnik
phone: +48 530 714 118
e-mail: [email protected]
Sponsor
Corza Medical GmbH
Bleicherweg 10;
8002 Zürich, Switzerland
Bleicherweg 10;
8002 Zürich, Switzerland
Please log in using the details provided
to identify you in the study.
to identify you in the study.